Susquehanna Fundamental Investments, LLC Poseida Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

  • $4.33 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$3.33 - $6.38 $34,788 - $66,651
10,447 New
10,447 $55,000
Q1 2021

May 17, 2021
SELL
$8.51 - $11.91 $473,930 - $663,279
-55,691 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$8.29 - $11.7 $86,589 - $122,206
-10,445 Reduced 15.79%
55,691 $611,000
Q3 2020

Nov 16, 2020
BUY
$8.09 - $16.25 $535,040 - $1.07 Million
66,136 New
66,136 $587,000

Others Institutions Holding PSTX

# of Institutions
98
Shares Held
38.5M
Call Options Held
377K
Put Options Held
22.2K
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $810M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email